Liana Ly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Liana Ly has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Alexandre C. Pereira
Harvard Medical School, Boston, MA, USA; Million Veteran Program Coordinating Center, Veterans Affairs Boston Healthcare System, Boston, MA, USA; Division of Aging, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of São Paulo, São Paulo, Brazil
2 shared publications- Brian R. Ferolito
Million Veteran Program Coordinating Center, Veterans Affairs Boston Healthcare System, Boston, MA, USA
2 shared publications - Bryan L. Peacker
Harvard Medical School, Boston, Massachusetts, USA; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA; Dermatology Section, VA Boston Healthcare System, Jamaica Plain, Massachusetts, USA
2 shared publications - Christy Zheng
Dermatology Section, Veterans Affairs Boston Healthcare System, Jamaica Plain, MA, USA; Harvard Medical School, Boston, MA, USA
2 shared publications - Jonathan C. Hwang
University of Pittsburgh School of Medicine, Pittsburgh, USA
2 shared publications - Kai Gravel-Pucillo
Million Veteran Program Coordinating Center, Veterans Affairs Boston Healthcare System, Boston, MA, USA
2 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by Elsevier in Journal of Investigative Dermatology
Vitiligo-associated variants and genes beyond immune-related loci: A genome-wide association and Mendelian randomization meta-analysis
- 16 October 2026
- Published by Elsevier in Journal of Investigative Dermatology
Open AccessVitiligo-associated variants and genes beyond immune-related loci: A genome-wide association and Mendelian randomization meta-analysis
- 17 January 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (7) , 1807-1815.e2
Multiomics analyses prioritize disease genes and pathways in hidradenitis suppurativa
- 17 January 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (7) , 1807-1815.e2
Multiomics analyses prioritize disease genes and pathways in hidradenitis suppurativa
- Open Access
- 5 March 2025
- Published by MDPI AG in Diabetology
- Vol. 6 (3) , 18
Dermatological Manifestations of Diabetes Mellitus and Its Complications
Diabetes mellitus (DM) is a chronic metabolic disorder associated with late diagnosis due to the absence of early symptoms in patients. Cutaneous manifestations of DM often serve as indicators of insulin resistance and vary with disease progression, highlighting severity and systemic involvements. With an increasing global burden and rapidly rising prevalence, skin findings associated with DM have become more crucial for the rapid identification and treatment of underlying metabolic processes. However, current challenges in identification include inaccurate or missed detection in darker-skinned populations, which may be attributed to the lack of inclusion of diverse skin types in textbooks and research studies. This review provides clinicians with comprehensive updates on the diagnosis and treatment of cutaneous signs, complications, comorbidities, medication-associated side effects associated with DM, and the treatment of these manifestations.
- 5 March 2025
- Published by MDPI AG in Diabetology
- Vol. 6 (3) , 18
Open AccessDermatological Manifestations of Diabetes Mellitus and Its Complications
Diabetes mellitus (DM) is a chronic metabolic disorder associated with late diagnosis due to the absence of early symptoms in patients. Cutaneous manifestations of DM often serve as indicators of insulin resistance and vary with disease progression, highlighting severity and systemic involvements. With an increasing global burden and rapidly rising prevalence, skin findings associated with DM have become more crucial for the rapid identification and treatment of underlying metabolic processes. However, current challenges in identification include inaccurate or missed detection in darker-skinned populations, which may be attributed to the lack of inclusion of diverse skin types in textbooks and research studies. This review provides clinicians with comprehensive updates on the diagnosis and treatment of cutaneous signs, complications, comorbidities, medication-associated side effects associated with DM, and the treatment of these manifestations.